151 related articles for article (PubMed ID: 6254651)
1. Calcitonin and 1,25-dihydroxyvitamin D3 receptors in human breast cancer cell lines.
Findlay DM; Michelangeli VP; Eisman JA; Frampton RJ; Moseley JM; MacIntyre I; Whitehead R; Martin TJ
Cancer Res; 1980 Dec; 40(12):4764-7. PubMed ID: 6254651
[TBL] [Abstract][Full Text] [Related]
2. Frequency of 1,25-dihydroxyvitamin D3 receptor in human breast cancer.
Eisman JA; Suva LJ; Sher E; Pearce PJ; Funder JW; Martin TJ
Cancer Res; 1981 Dec; 41(12 Pt 1):5121-4. PubMed ID: 6272989
[TBL] [Abstract][Full Text] [Related]
3. Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture.
Frampton RJ; Suva LJ; Eisman JA; Findlay DM; Moore GE; Moseley JM; Martin TJ
Cancer Res; 1982 Mar; 42(3):1116-9. PubMed ID: 6277475
[TBL] [Abstract][Full Text] [Related]
4. 1,25-dihydroxyvitamin D3 receptors in human epithelial cancer cell lines.
Colston K; Colston MJ; Fieldsteel AH; Feldman D
Cancer Res; 1982 Mar; 42(3):856-9. PubMed ID: 6895862
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites.
Frampton RJ; Omond SA; Eisman JA
Cancer Res; 1983 Sep; 43(9):4443-7. PubMed ID: 6307514
[TBL] [Abstract][Full Text] [Related]
6. Properties of a calcitonin receptor and adenylate cyclase in BEN cells, a human cancer cell line.
Findlay DM; deLuise M; Michelangeli VP; Ellison M; Martin TJ
Cancer Res; 1980 Apr; 40(4):1311-7. PubMed ID: 6244091
[TBL] [Abstract][Full Text] [Related]
7. Calcitonin effects on growth and on selective activation of type II isoenzyme of cyclic adenosine 3':5'-monophosphate-dependent protein kinase in T 47D human breast cancer cells.
Ng KW; Livesey SA; Larkins RG; Martin TJ
Cancer Res; 1983 Feb; 43(2):794-800. PubMed ID: 6184157
[TBL] [Abstract][Full Text] [Related]
8. Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture.
Fitzpatrick SL; LaChance MP; Schultz GS
Cancer Res; 1984 Aug; 44(8):3442-7. PubMed ID: 6331647
[TBL] [Abstract][Full Text] [Related]
9. 20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines.
Elstner E; Linker-Israeli M; Said J; Umiel T; de Vos S; Shintaku IP; Heber D; Binderup L; Uskokovic M; Koeffler HP
Cancer Res; 1995 Jul; 55(13):2822-30. PubMed ID: 7796409
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of calcitonin induction of prolonged activation of adenylate cyclase in human cancer cells.
Michelangeli VP; Findlay DM; Moseley JM; Martin TJ
J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(2):129-41. PubMed ID: 6315797
[TBL] [Abstract][Full Text] [Related]
11. 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death.
Wang Q; Yang W; Uytingco MS; Christakos S; Wieder R
Cancer Res; 2000 Apr; 60(7):2040-8. PubMed ID: 10766196
[TBL] [Abstract][Full Text] [Related]
12. Hormone-dependent transformation and nuclear localisation of 1,25-dihydroxyvitamin D3 receptors from human breast cancer cell lines and chick duodenum.
Sher E; Martin TJ; Eisman JA
Horm Metab Res; 1985 Mar; 17(3):147-51. PubMed ID: 2987093
[TBL] [Abstract][Full Text] [Related]
13. 1,25-dihydroxyvitamin D3 specifically binds to a human breast cancer cell line (T47D) and stimulates growth.
Freake HC; Marcocci C; Iwasaki J; MacIntyre I
Biochem Biophys Res Commun; 1981 Aug; 101(4):1131-8. PubMed ID: 6272774
[No Abstract] [Full Text] [Related]
14. Characterization of a receptor-like protein for 1,25-dihydroxyvitamin D3 in rat skin.
Simpson RU; DeLuca HF
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5822-6. PubMed ID: 6255467
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long-term tissue culture.
Imai Y; Leung CK; Friesen HG; Shiu RP
Cancer Res; 1982 Nov; 42(11):4394-8. PubMed ID: 6290036
[TBL] [Abstract][Full Text] [Related]
16. Stimulatory effect of 1,25-dihydroxyvitamin D3 on the glucose-6-phosphate dehydrogenase activity in the MCF-7 human breast cancer cell line.
Noun A; Garabedian M; Monet JD
Cell Biochem Funct; 1989 Jan; 7(1):1-6. PubMed ID: 2752532
[TBL] [Abstract][Full Text] [Related]
17. Normal and malignant breast tissue is a target organ for 1,25-(0H)2 vitamin D3.
Eisman JA; Macintyre I; Martin TJ; Frampton RJ; King RJ
Clin Endocrinol (Oxf); 1980 Sep; 13(3):267-72. PubMed ID: 6260398
[TBL] [Abstract][Full Text] [Related]
18. Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration.
Murphy LJ; Murphy LC; Vrhovsek E; Sutherland RL; Lazarus L
Cancer Res; 1984 May; 44(5):1963-8. PubMed ID: 6324992
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of human breast cancer cells by 1,25-dihydroxyvitamin D3 is accompanied by induction of apolipoprotein D expression.
López-Boado YS; Puente XS; Alvarez S; Tolivia J; Binderup L; López-Otín C
Cancer Res; 1997 Sep; 57(18):4091-7. PubMed ID: 9307298
[TBL] [Abstract][Full Text] [Related]
20. Measurement of 1,25-dihydroxyvitamin D3 receptors in breast cancer and their relationship to biochemical and clinical indices.
Freake HC; Abeyasekera G; Iwasaki J; Marcocci C; MacIntyre I; McClelland RA; Skilton RA; Easton DF; Coombes RC
Cancer Res; 1984 Apr; 44(4):1677-81. PubMed ID: 6322984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
